ISU Abxis

086890 · KOSDAQ · Health Care · SMALL CAP

Net income turned to a loss.

ISU Abxis reported separate results for FY2025: revenue of US$38.8M (−6% year on year), operating profit of US$1.12M (−87.8% year on year) and a net loss of US$7.31M (from a profit a year earlier).

Earnings(Change of 30% or more in revenue or profit/loss structure (15% for large companies))· FILED 2026-02-05· RCEPT 20260205901241

US$38.8MRevenue
−6%Revenue vs a year earlier
US$1.12MOperating profit

Converted at 1 USD ≈ ₩1,460.11 (filing-date rate, 2026-02-05 close)

A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-02-05) →

What happened

ISU Abxis reported separate results for FY2025: revenue of US$38.8M (−6% year on year), operating profit of US$1.12M (−87.8% year on year) and a net loss of US$7.31M (from a profit a year earlier).

Korean rules require this filing when revenue or profit moves 30% or more from the prior year (15% for large companies). The figures are the company's own and may not be audited yet.

RevenueUS$38.8M
Revenue vs a year earlier−6%
Operating profitUS$1.12M
Net income−US$7.31M
PeriodFY2025 (separate)
Filed2026-02-05, Change of 30% or more in revenue or profit/loss structure (15% for large companies)
SourceDART rcept 20260205901241 → open original filing

Versions of this filing

  1. 2026-02-05Original (this page)
  2. 2026-02-05Amendment 1

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-02-05 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.